Qiagen NV (XTER:QIA) Current Accrued Expense : €172 Mil (As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Qiagen NV Current Accrued Expense?

Qiagen NV's Current Accrued Expense for the quarter that ended in Dec. 2023 was €172 Mil.

Qiagen NV's quarterly Current Accrued Expense declined from Jun. 2023 (€364 Mil) to Sep. 2023 (€325 Mil) and declined from Sep. 2023 (€325 Mil) to Dec. 2023 (€172 Mil).

Qiagen NV's annual Current Accrued Expense increased from Dec. 2021 (€175 Mil) to Dec. 2022 (€178 Mil) but then declined from Dec. 2022 (€178 Mil) to Dec. 2023 (€172 Mil).

Qiagen NV Current Accrued Expense Historical Data

The historical data trend for Qiagen NV's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Current Accrued Expense Chart

Qiagen NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

289.26

162.18

175.13

178.27

172.36

Qiagen NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Accrued Expense	Get a 7-Day Free Trial															178.27	385.38	364.00	325.02	172.36

Qiagen NV Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Qiagen NV Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV (XTER:QIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (XTER:QIA) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany QGEN:Austria

Address

Hulsterweg 82, Venlo, LI, NLD, 5912 PL

Website

https://www.qiagen.com

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (over 45% of 2022 sales), followed by EMEA (nearly 35%), and Asia-Pacific (nearly 20%).

Qiagen NV (XTER:QIA) Headlines

No Headlines